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Abstract
Introduction The objective of the present study was to compare
postoperative cardiac troponin I (cTnI) release and the
thresholds of cTnI that predict adverse outcome after elective
coronary artery bypass graft (CABG), after valve surgery, and
after combined cardiac surgery.
Methods Six hundred and seventy-five adult patients
undergoing conventional cardiac surgery with cardiopulmonary
bypass were retrospectively analyzed. Patients in the CABG (n
= 225) and valve surgery groups (n = 225) were selected after
matching (age, sex) with those in the combined surgery group
(n = 225). cTnI was measured preoperatively and 24 hours after
the end of surgery. The main endpoint was a severe
postoperative cardiac event (sustained ventricular arrhythmias
requiring treatment, need for inotropic support or intraaortic
balloon pump for at least 24 hours, postoperative myocardial
infarction) and/or death. Data are presented as the median and
the odds ratio (95% confidence interval).
Results Postoperative cTnI levels were significantly different
among the three groups (combined surgery, 11.0 (9.5–13.1)
ng/ml versus CABG, 5.2 (4.7–5.7) ng/ml and valve surgery, 7.8
(7.6–8.0) ng/ml; P < 0.05). The thresholds of cTnI predicting
severe cardiac event and/or death were also significantly
different among the three groups (combined surgery, 11.8
(11.5–14.8) ng/ml versus CABG, 7.8 (6.7–8.8) ng/ml and valve
surgery, 9.3 (8.0–14.0) ng/ml; P  < 0.05). An elevated cTnI
above the threshold in each group was significantly associated
with a severe cardiac event and/or death (odds ratio, 4.33
(2.82–6.64)).
Conclusion The magnitude of postoperative cTnI release is
related to the type of cardiac surgical procedure. Different
thresholds of cTnI must be considered according to the
procedure type to predict early an adverse postoperative
outcome.
Introduction
Cardiac troponin I (cTnI) is a highly sensitive and specific bio-
logical marker of myocardial necrosis [1]. In noncardiac sur-
gery the definition of abnormal cTnI release during the
postoperative period has been modified in past years, as a
result of better understanding of the pathophysiological mech-
anisms involved in postoperative myocardial necrosis [2-4].
The most recent definition stipulates that any increase in cTnI
above the normal range should be considered an indication of
myocardial necrosis [5].
The problem is far more complex in cardiac surgery with cardi-
opulmonary bypass (CPB) since cardiac surgery per se
induces an increase in postoperative cTnI, even in the absence
of postoperative cardiac complications [6-8]. CPB is associ-
ated with a certain degree of myocardial damage, and its
CABG = coronary artery bypass grafting; CI = confidence interval; CPB = cardiopulmonary bypass; cTnI = cardiac troponin I; ICU = cardiac intensive 
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duration is likely to influence the postoperative cTnI release
[9]. This increase could also depend on the type of surgery
and its subsequent degree of direct surgical trauma [9,10].
Indeed, valve replacement may induce more direct surgical
trauma than coronary artery bypass graft (CABG) surgery,
whereas combined surgery is associated with a more pro-
longed CPB time.
Whatever the various mechanisms that explain the postopera-
tive cTnI release in cardiac surgery, it has been shown that
cTnI is an independent predictor of short-term and long-term
adverse outcome in cardiac surgical patients [11,12]. The def-
inition of the threshold of postoperative cTnI release associ-
ated with a poor outcome may therefore be of paramount
importance in cardiac surgery to identify a transition in postop-
erative risk. At the present time there is little information con-
cerning the methodology used to determine the threshold of
postoperative cTnI, and the precision of this threshold deter-
mination has never been studied. Moreover, whether the
potential differences in cTnI release among procedure types
may influence, first, the threshold of cTnI associated with an
adverse postoperative outcome and, second, the accuracy of
cTnI to predict such an adverse outcome remains unknown.
Finally, patients undergoing combined cardiac surgery are well
known to have a higher risk of postoperative morbidity and
mortality than those undergoing single procedures [11,13,14].
Whether this latter issue influences the accuracy of cTnI to
predict a poor outcome remains also unknown.
We therefore decided to conduct a comparative study
between CABG, valve surgery, and combined surgery in order
to determine the postoperative cTnI release and the thresh-
olds of cTnI that predict adverse outcome – the hypothesis
tested being that both cTnI release and the thresholds would
differ among procedure types. In addition, we proposed a
method to evaluate the precision of the threshold
determination.
Materials and methods
Patient population
We used a comprehensive, prospectively recorded database
describing the clinical and surgical characteristics of 2,875
patients undergoing cardiac surgery with CPB at the Centre
Hospitalier Privé Saint-Martin (Caen, France) from January
1999 to October 2004. An anesthesiologist (JLF) entered the
data, and a systematic audit by a trained research technician
who participated in previous studies [12,13] allowed verifica-
tion of the accuracy in coding data. Missing data were coded
as absent. The study was approved by an institutional review
board (Comité Consultatif pour la Protection des Personnes
se prêtant à la Recherche Biomédicale Pitié-Salpêtrière, Paris,
France). Because data were collected during routine care of
patients that conformed to standard procedures currently
used in our institution, authorization was granted to waive writ-
ten informed consent.
Inclusion criteria were elective CABG, aortic valve or mitral
valve replacement surgery, and combined surgery (CABG
plus aortic valve or mitral valve replacement). Patients with
increased risk of postoperative cardiac morbidity and mortality
or of cTnI release (n = 475 patients, 17%) were excluded:
emergency surgery in <24 hours (n = 86 patients, 3%), reop-
erative procedures (n = 58 patients, 2%), recent history (<4
weeks) of acute myocardial infarction and abnormal preopera-
tive cTnI values >0.6 ng/ml (n = 101 patients, 4%), and vari-
ous other surgical procedures (n  = 230 patients, 8%)
including valve repair and aortic valve plus mitral valve replace-
ment. Among the remaining 2,400 patients, because we did
not have the capability to verify accurately the characteristics
of every patient in the whole population, and because the
power of the study was mainly related to the sample size of the
smallest group, we decided to select three groups of patients
of similar size by matching the participants according to age
and sex. For each patient in the combined surgery group we
therefore randomly selected a matched patient in the valve sur-
gery group and a matched patient in the CABG surgery group
(Figure 1).
Perioperative management
All patients were premedicated with oral lorazepam (2.5 mg
the day before surgery and 2.5 mg on the morning of surgery).
β-blocking agents were given until the day of surgery in chron-
ically treated patients. Standardized total intravenous anesthe-
sia (target control propofol infusion, remifentanil, and
pancuronium bromide) and standard monitoring techniques
(five-lead electrocardiogram with computerized analysis of the
ST segment and invasive arterial blood pressure) were used in
all patients and complied with routine practice at our hospital
[12,13]. Antifibrinolytic therapy, either tranexamic acid (15
mg/kg twice) or aprotinin (2 × 106 KIU pre-CPB, 2 × 106 KIU
in prime, and 500,000 KIU/hour during surgery) was routinely
administered. CPB was performed under normothermia
(>34.5°C) in all types of surgery and myocardial protection
Figure 1
Profile of the study group Profile of the study group. CABG, coronary artery bypass graft surgery.Available online http://ccforum.com/content/11/5/R106
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was achieved by intermittent anterograde or combined (anter-
ograde plus retrograde) warm blood cardioplegia, as previ-
ously described [12,13]. After termination of CPB,
catecholamines were used when necessary, at the discretion
of the attending anesthesiologist.
All patients were admitted postoperatively into the cardiac
intensive care unit (ICU) for at least 48 hours. Standard post-
operative care included assessment for tracheal extubation
within 1–8 hours of arrival in the ICU, blood glucose control
(<8 mmol/l), intravenous heparin (200 U/kg) in patients with
valve disease, and aspirin (300 mg, oral or intravenous) and a
low-molecular-weight heparin (nadroparin 2,850 U, anti-acti-
vated factor X, subcutaneous; Fraxiparine®; Sanofi-Synthe-
labo, Paris, France) in patients with coronary artery disease,
beginning 6 hours after surgery in the absence of significant
mediastinal bleeding (>50 ml/hour). β-blocking agents were
continued postoperatively in chronically treated patients.
Measurements of cardiac troponin I concentration
Blood samples were collected the day before surgery and 24
hours after the end of surgery. This single postoperative time
point was chosen in accordance with previous reports show-
ing that serum cTnI values peak at 20–24 hours after cardiac
surgery [6,7,15], and with reports showing that a single 24-
hour cTnI value is a significant predictor of increased postop-
erative ICU stay and hospital stay [16] and is an independent
predictor of short-term and long-term adverse outcome in car-
diac surgical patients [11,12]. A technician who was unaware
of the clinical and electrocardiogram data performed the
assays. cTnI was analyzed with a sensitive and highly specific
immunoenzymometric assay (AxSYM Troponin-I MEIA assay;
Abbott Laboratories, Rungis, France) that detects both free
troponin and complex-bound troponin. The assay allows the
detection of cTnI within the range of 0.3–50 ng/ml with appro-
priate dilutions. Values >0.6 ng/ml were considered abnormal.
The within-run coefficient of variation was 6% and the
between-run coefficient of variation was 11%.
Clinical outcome
The duration of hospitalization, the length of stay in the ICU,
and the inhospital mortality were recorded. As previously
described [17], to enable comparison of the duration of hospi-
talization and the length of stay in the ICU in different groups
while taking deaths into account, we calculated the number of
hospital-free days and ICU-free days within 1 month after
admission, all dead patients being scored 0 hospital-free days
and 0 ICU-free days. To analyze the inhospital outcome, the
following postoperative variables were also recorded: duration
of postoperative ventilation, Simplified Acute Physiologic
Score [18], reoperation rate within hospital, and cardiac and
noncardiac complications. Cardiac complications included
new atrial fibrillation or flutter, sustained ventricular arrhyth-
mias requiring treatment, requirement of an inotropic agent for
at least 24 hours, use of an intraaortic balloon pump in the
ICU, and postoperative myocardial infarction.
Diagnostic criteria for postoperative myocardial infarction
were the appearance of new Q waves of more than 0.04 s and
1 mm deep, or a reduction in R waves of more than 25% in at
least two continuous leads of the same vascular territory, as
previously described [12,13]. Daily 12-lead electrocardiogram
recordings were assessed by two experienced physicians
blinded to the clinical and biochemical information. Postoper-
ative noncardiac complications included stroke, gastrointesti-
nal bleeding or ischemia, sepsis, and renal dysfunction.
Postoperative renal dysfunction was defined as ≥ 30%
increase in the preoperative-to-maximum postoperative serum
creatinine level within 7 days after surgery [19].
End points
Severe postoperative cardiac events and death were chosen
as study endpoints. A severe postoperative cardiac event was
defined as one of the following: any postoperative sustained
ventricular arrhythmia requiring treatment; a need for inotropic
support for at least 24 hours; a need for an intraaortic balloon
pump for at least 24 hours in the ICU; or postoperative myo-
cardial infarction as defined above and previously [12,13].
Death was defined as death at any time during the hospital
stay. Causes of death were recorded and classified as cardiac
(heart failure, myocardial infarction, ventricular arrhythmia) or
noncardiac (hemorrhage, respiratory failure, sepsis, or other
causes). Because of the rare occurrence of death, the primary
endpoint was a composite endpoint defined as the occur-
rence of severe cardiac event and/or death.
Statistical analysis
Following a preliminary study, we made the hypothesis that the
composite endpoint occurred in 15% of patients in the CABG
group and in 30% of patients in the combined surgery group.
Assuming an α risk of 0.05 (including the Bonferroni correc-
tion for three groups) and a β risk of 0.10, we determined that
at least 210 patients should be included in each group
(NQuery Advisor 3.0; Statistical Solutions Ltd, Cork, Ireland).
Nevertheless, it should be pointed out that this calculation did
not refer to the main objective of the study, which was to com-
pare the cTnI thresholds among groups. Since we were not
able to provide such calculation, we decided to calculate a
posteriori the smallest difference in the cTnI threshold (versus
the CABG group) that we were able to detect in our study.
Data are expressed as the mean ± standard deviation, as the
median (95% confidence interval (CI)) for nonnormally distrib-
uted variables, or as the number (percentage with its 95% CI).
Comparison of several means was performed using analysis of
variance and the Newman-Keuls post-hoc test, using the
Kruskall–Wallis test with Bonferroni correction, or using
Fisher's exact method with Bonferroni correction, as appropri-
ate. We determined the receiver operating characteristicsCritical Care    Vol 11 No 5    Fellahi et al.
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(ROC) curve and calculated the area under the ROC curve
and its 95% CI. Comparison of areas under the ROC curve
was performed using a nonpaired method.
The ROC curve was used to determine the best threshold for
cTnI to predict the occurrence of severe cardiac event and/or
death. The best threshold was the one that minimized the dis-
tance to the ideal point (sensitivity = specificity = 1) on the
ROC curve. As this method does not provide any CI of the
threshold, we realized a bootstrap analysis to obtain a calcula-
tion of the best threshold and its 95% CI. Bootstrap was per-
formed using 1,000 random samples of 75% of the population
studied. To verify that the incidence of a poor outcome (which
was expected to be different among groups) did not influence
the troponin thresholds, we randomly selected two subgroups
of patients: one in the CABG population with a high incidence
of the composite endpoint (comparable with that of the global
combined surgery group), and one in the combined surgery
population with a low incidence of the composite endpoint
(comparable with that of the global CABG group). We then
calculated the thresholds of troponin using the ROC curve
and their 95% CI values using the bootstrap analysis, as indi-
cated above. Assessment of the diagnostic performance of an
elevated cTnI to predict the outcome was performed by calcu-
lating the sensitivity, specificity, positive and negative predic-
tive values, and accuracy (defined as the sum of concordant
cells divided by the sum of all cells in the two-by-two table) and
their 95% CI values.
We performed a multiple, forward, stepwise logistic regres-
sion to assess variables associated with the composite end-
point (severe cardiac event and/or death). We used a limited
approach and included only the significant preoperative varia-
bles in the univariate analysis (P value of entry = 0.10), except
for two variables thought to be prognostic (diabetes, age) that
were systematically included in the model. The Spearman
coefficient matrix correlation was used to identify significant
colinearity (>0.70) between variables. The odds ratios and
their 95% CI of variables selected by the logistic model were
calculated. The discrimination of the model was assessed
using the calculation of the area under the ROC curve (or c-
statistics). The percentage of patients correctly classified by
the logistic model was calculated using the best threshold
determined by the ROC curve. Calibration of the model was
assessed using the Hosmer-Lemeshow statistic (P > 0.05 for
no significant difference between the predictive model and the
observed data) [20].
P < 0.05 was considered significant and all P values were
two-tailed. Statistical analyses were performed using NCSS
2001 software (Statistical Solutions Ltd) and SPSS 13.0 soft-
ware (SPSS Corporation, Chicago, IL, USA). Randomization
was obtained using either the Excel random function (Micro-
soft, Seattle, WA, USA) or that of the SPSS software.
Results
The three groups of patients differed according to the inci-
dence of diabetes, previous stroke, hypertension, preoperative
medications taken, and durations of CPB and aortic cross-
clamping (Table 1). The postoperative outcome also differed
between groups, as shown by a higher incidence of severe
cardiac events, and decreased values of ICU-free and hospi-
tal-free days in combined surgery (Table 2). As expected, the
rare occurrence of death precluded any powerful analysis of
inhospital death (Table 2).
Postoperative cTnI values were lacking in 29 patients (4%).
The median postoperative values of cTnI were significantly dif-
ferent among groups (Table 3). These differences remained
significant when patients with severe cardiac event and/or
death were excluded (Table 3). We calculated that we had the
power (80%) to detect a difference of cTnI of at least 0.6 ng/
ml, compared with the CABG group. There were no significant
differences among groups in the area under the ROC curve,
whereas there were significant differences in the threshold of
cTnI predicting either severe cardiac event and/or death
(Table 4). Despite the use of a specific threshold in each
group, the accuracy of cTnI was greater in the CABG surgery
group than in the valve surgery or combined surgery groups
(Table 5). The specificity and the negative predictive value
were significantly less in the combined surgery group than in
the CABG group (Table 5).
In the CABG subgroup of patients (n = 100) with a high inci-
dence of the composite endpoint (comparable with that of the
global combined surgery group, 33% versus 34%; not signifi-
cant), the cTnI threshold was 7.6 (95% CI, 6.7–9.7) ng/ml and
was not significantly different from that of the global CABG
population. In the combined surgery subgroup of patients (n =
175) with a low incidence of the composite endpoint (compa-
rable with that of the global CABG group, 15% versus 15%;
not significant), the cTnI threshold was 13.8 (95% CI, 12.2–
15.1) ng/ml and was not significantly different from that of the
global combined surgery population. The difference in cTnI
threshold between these two subgroups was significant (P <
0.001).
We compared patients with severe cardiac events and/or
death (n = 158) and those patients without (n = 517). In the
univariate analysis, there were significant differences in the
incidence of chronic obstructive pulmonary disease (16% ver-
sus 8%, P = 0.002), in treatment using diuretics (53% versus
30%, P < 0.001), in left ventricular ejection fraction <50%
(21% versus 8%, P < 0.001), in Euroscore [21] (6 (5–6) ver-
sus 5 (5–6), P = 0.003), in creatinine clearance (53 ± 19 ml/
min versus 62 ± 21 ml/min, P = 0.04), in CPB duration (123
± 34 min versus 105 ± 34 min, P < 0.001), in type of surgery
(CABG, 15% versus 85%; valve surgery, 21% versus 79%;
combined surgery, 49% versus 66%; P  < 0.001), in cTnI
(15.6 (13.3–17.6) versus 7.0 (6.7–7.4) ng/ml, P < 0.001),Available online http://ccforum.com/content/11/5/R106
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and in the proportion of patients with an elevated cTnI (69%
versus 27%, P < 0.001), according to the thresholds defined
in each group. In the logistic model, only five variables were
significantly associated with severe cardiac event and/or
death: an elevated cTnI, a left ventricular ejection fraction
<50%, treatment by diuretics, chronic obstructive pulmonary
disease, and the duration of CPB (Table 6). There was no sig-
nificant correlation between these variables, except for a weak
correlation between cTnI and CPB duration (R = 0.16, P <
0.001). Adding interactions between variables did not improve
the logistic model. The model provided good discrimination
(area under the ROC curve, 0.774 (95% CI, 0.730–0.819);
71% of patients being appropriately classified) and calibration
(Hosmer-Lemeshow chi-square test = 8.58, not significant).
Discussion
Our study demonstrates that postoperative cTnI release in
conventional adult cardiac surgery with CPB depends on the
type of surgery, even in the absence of an adverse postopera-
tive outcome; that different thresholds of cTnI according to the
procedure type should be considered to predict a poor
outcome; and that the accuracy of cTnI to predict a poor out-
come may be different among procedure types.
Postoperative cTnI release was significantly different among
the three groups of surgery. cTnI was increased in patients
undergoing combined surgery when compared with CABG
patients and valve surgery patients, while CABG surgery was
associated with the lowest postoperative cTnI level. The differ-
ences remained significant when patients with severe cardiac
event and/or death were excluded from the analysis. These
results suggest that the 'basal release' of cTnI in cardiac sur-
gery depends on the type of surgery and is increased in com-
plex and prolonged surgical procedures. A more extensive
direct surgical trauma to the myocardium and an increase in
both aortic cross-clamping and CPB time could explain this
higher cTnI release in valve surgery, and especially in com-
bined surgery. Our study showed significant correlation
between the duration of CPB and postoperative cTnI release.
By contrast, CABG per se does not lead to a major release of
Table 1
Baseline characteristics of patients undergoing coronary artery bypass graft, valve surgery, or combined cardiac surgery
Characteristic Coronary artery bypass graft (n = 225) Valve surgery (n = 225) Combined surgery (n = 225)
Age (years) 73 ± 8 73 ± 8 73 ± 8
Men 145 (64) 145 (64) 145 (64)
Women 80 (36) 80 (36) 80 (36)
Body mass index (kg/m2) 27.0 ± 3.9 26.8 ± 4.0 26.4 ± 4.0
Euroscore 5 (4–5) 5 (5-5) 7 (6–7)* †
Diabetes mellitus 45 (20) 24 (11)* 44 (20)†
Chronic obstructive pulmonary disease 21 (9) 33 (15) 13 (6)†
Hypertension 169 (75) 134 (60)* 145 (64)*
Stroke 19 (8) 5 (2)* 10 (4)*
Left ventricular ejection fraction (%) 65 ± 12 65 ± 10 64 ± 13
Serum creatinine (μmol/l) 100 ± 42 97 ± 19 100 ± 40
Creatinine clearance (ml/min) 61 ± 20 62 ± 20 60 ± 21
Preoperative medication
Nitrates 166 (52) 54 (24)* 66 (29)*
Calcium blockers 76 (34) 35 (16)* 56 (25)* †
β-blockers 144 (64) 44 (20)* 83 (37)* †
Renin – angiotensin system inhibitors 102 (45) 93 (41) 66 (29)* †
Diuretics 31 (14) 93 (41)* 114 (51)* †
Surgery
Cardiopulmonary bypass time (min) 90 ± 22 99 ± 20* 138 ± 27* †
Aortic cross-clamping time (min) 46 ± 13 68 ± 13* 96 ± 19* †
Data expressed as the mean ± standard deviation, the number (%), or the median (95% confidence interval). *P < 0.05 versus coronary artery 
bypass graft; †P < 0.05 versus valve surgery. No statistical analysis was performed on age and sex, which were matching variables between 
groups.Critical Care    Vol 11 No 5    Fellahi et al.
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Table 2
Postoperative outcome in patients undergoing coronary artery bypass graft, valve surgery, or combined cardiac surgery
Outcome Coronary artery bypass graft
(n = 225)
Valve surgery
(n = 225)
Combined surgery
(n = 225)
Duration of postoperative ventilation (hours) 7 (7-7) 7 (7-7) 7 (6–7)
Intensive care unit-free days 26 ± 4 26 ± 4 24 ± 7* †
Hospital-free days 21 ± 4 21 ± 5 20 ± 6*
Simplified Acute Physiologic Score II score 30 (29–30) 30 (29–30) 30 (29–31)
Reoperation 5 (2) 5 (2) 10 (4)
Cardiac complications
New-onset atrial fibrillation 73 (32) 86 (38) 74 (33)
Ventricular arrhythmia 14 (6) 19 (8) 37 (16)* †
Inotropic support and/or intraaortic balloon pump >24 hours 24 (11) 35 (16) 44 (20)*
Myocardial infarction 8 (4) 3 (1) 22 (10)* †
Noncardiac complications
Stroke 3 (1) 4 (2) 3 (1)
Gastrointestinal 2 (1) 9 (4) 4 (2)
Sepsis 10 (4) 11 (5) 22 (10)*
Renal dysfunction 25 (11) 34 (15) 42 (19)
Severe cardiac eventa 33 (15) 47 (21) 75 (33)* †
Inhospital death 3 (1) 5 (2) 10 (4)
Severe cardiac event and/or death 33 (15) 48 (21) 77 (34)* †
Data expressed as the median (95% confidence interval), the mean ± standard deviation, or the number (%). *P < 0.05 versus coronary artery 
bypass graft; †P < 0.05 versus valve surgery. aDefined as ventricular arrhythmia and/or inotropic support for at least 24 hours/intraaortic balloon 
pump for at least 24 hours and/or myocardial infarction (see Materials and methods).
Table 3
Postoperative cardiac troponin I in patients undergoing coronary artery bypass graft, valve surgery, or combined cardiac surgery
Coronary artery bypass graft Valve surgery Combined surgery
All patients
n 215 215 216
Cardiac troponin I (ng/ml) 5.2 (4.7–5.7) 7.8 (7.6–8.0)* 11.0 (9.5–13.1)*†
Elevated cardiac troponin Ia 49 (27) 77 (36)* 101 (47)*†
Patients without severe cardiac event or death
n 183 168 142
Cardiac troponin I (ng/ml) 5.1 (4.1–5.2) 7.8 (7.3–7.8)* 9.1 (8.0–10.1)*†
Elevated cardiac troponin Ia 37 (20) 48 (29) 47 (33)*
Patients with severe cardiac event or death
n 32 47 74
Cardiac troponin I (ng/ml) 13.7 (6.8–30.4) 14.1 (8.1–17.8) 16.5 (14.7–19.2)*†
Elevated cardiac troponin Ia 22 (69) 29 (62) 54 (73)*
Data expressed as the median (95% confidence interval) or the number (%).* P < 0.05 versus coronary artery bypass graft; †P < 0.05 versus valve 
surgery. aAbove the threshold in each group as indicated in Table 4.Available online http://ccforum.com/content/11/5/R106
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cTnI, as previously shown [22]. Since we previously found in
elective CABG surgery that the overall amount of cardiac cells
injured (whatever the mechanisms of myocardial tissue insult)
was reflected by postoperative cTnI release and was well cor-
related with the short-term and long-term clinical outcome
[12], it is probable that both an increase in basal postoperative
cTnI release and the worst outcome are linked in combined
surgery.
The postoperative cTnI thresholds that predict the occurrence
of severe cardiac events and/or death were significantly differ-
ent among the three groups. The threshold was significantly
higher in combined surgery and was lower in CABG surgery.
Again, a probable explanation is that surgical trauma is less in
CABG than that in valve surgery or combined surgery and that
the duration of CPB plays a role in the postoperative release
of cTnI in the absence of cardiac complications. Our study
highlights the necessity to consider the type of cardiac surgery
in analyzing postoperative cTnI release in clinical practice. It
should also be pointed out that no previous study has focused
on the comparison of thresholds determined using the ROC
methodology in different population. Even the 95% CI of the
Table 4
Analysis of the receiver operating curve (ROC) and determination of the thresholds of cardiac troponin I predicting the occurrence 
of postoperative severe cardiac event and/or death in patients undergoing coronary artery bypass graft surgery, valve surgery, or 
combined cardiac surgery, and in the global population
Area under the ROC curve Cardiac troponin I threshold (ng/ml)
Coronary artery bypass graft (n = 215) 0.777 (0.683–0.871) 7.8 (6.7–8.8)
Valve surgery (n = 215) 0.661 (0.559–0.763) 9.3 (8.0–14.0)*
Combined surgery (n = 216) 0.707 (0.634–0.780) 11.8 (11.5–14.8)*†
Global population (n = 646) 0.740 (0.693–0.787) 10.4 (8.9–11.8)
Data expressed as the median (95% confidence interval). Bootstrap analysis (1,000 random sample of 75% of the population, see Materials and 
methods). *P < 0.05 versus coronary artery bypass graft; †P < 0.05 versus valve surgery. No statistical comparison was performed versus the 
global population values.
Table 5
Assessment of the diagnostic performance of an elevated cardiac troponin I to predict a severe cardiac event and/or death
Coronary artery bypass 
graft (n = 215)
Valve surgery (n = 215) Combined surgery (n = 
216)
Global population (n = 
646)
Sensitivity 0.69 (0.51–0.82) 0.62 (0.47–0.74) 0.73 (0.62–0.82) 0.69 (0.61–0.75)
Specificity 0.80 (0.73–0.85) 0.71 (0.64–0.78) 0.67 (0.59–0.74)* 0.73 (0.69–0.77)
Positive predictive value 0.37 (0.26–0.50) 0.38 (0.28–0.49) 0.53 (0.44–0.63)*† 0.44 (0.38–0.51)
Negative predictive value 0.94 (0.89–0.97) 0.87 (0.80–0.92) 0.83 (0.75–0.88)* 0.88 (0.85–0.91)
Accuracy 0.79 (0.72–0.83) 0.69 (0.63–0.75)* 0.69 (0.63–0.75)* 0.72 (0.68–0.75)
Data expressed as the median (95% confidence interval). *P < 0.05 versus coronary artery bypass graft; †P < 0.05 versus valve surgery. No 
statistical comparison was performed versus the global population values. The threshold in each group was that indicated in Table 4.
Table 6
Variables associated with postoperative severe cardiac event and/or death (n = 628)
Variable Odds ratio (95% confidence interval) P value
Elevated cardiac troponin Ia 4.33 (2.82–6.64) <0.001
Left ventricular ejection fraction <50% 2.31 (1.31–4.05) 0.004
Diuretics 1.88 (1.23–2.88) 0.004
Chronic pulmonary obstructive disease 1.95 (1.05–3.64) 0.04
Cardiopulmonary bypass time (per 1 min 
increase)
1.0110 (1.0043–1.0175) 0.0012
aAbove the threshold in each group as indicated in Table 4.Critical Care    Vol 11 No 5    Fellahi et al.
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best threshold was not provided in any previous study [6-
13,15] although this information is of paramount importance.
The use of the bootstrap technique enabled us to provide both
the 95% CI of the thresholds and to compare them between
different populations. This method should probably be more
widely used to assess the clinical relevance of new biological
markers [1].
The diagnostic performance of an elevated serum cTnI con-
centration to predict severe cardiac events and/or death was
good, whatever the type of cardiac surgery, as previously
shown [11,12]. Nevertheless, despite the determination of a
particular threshold in each type of cardiac surgery, the accu-
racy of cTnI was significantly greater in CABG than in valve
surgery or combined surgery, and the specificity of cTnI was
less in combined surgery than in CABG surgery. This result is
not surprising since a higher 'basal' cTnI release may have
masked some small releases of cTnI due to myocardial necro-
sis induced by causes other than direct surgical trauma and/
or CPB. In contrast, an increase in postoperative cTnI after
CABG surgery is more closely related to additional ischemic
myocardial damage, postoperative cardiac complications, and
poor outcome. An elevated postoperative cTnI release was a
strong and independent predictor of severe cardiac events
and inhospital death after conventional cardiac surgery, what-
ever the type of surgery. A high cTnI level was associated with
a fourfold increase in the risk of cardiac morbidity and mortal-
ity, according to the thresholds defined in each group. This lat-
ter result is consistent with previous results from pooled adult
cardiac patients [11] and with results in elective CABG sur-
gery [12].
Some remarks must be included to assess the limitations of
our study. First, although data were entered prospectively into
the database, this was a retrospective study with the usual lim-
itations associated with such methodology.
Second, the study period was long. Even if no significant
changes occurred in overall anesthetic and surgical manage-
ment, we cannot preclude some minor changes that could
have finally influenced the postoperative outcome of the
patients.
Third, the matching process we used in the present study was
not designed to match the risk stratification between groups,
but rather to select three groups of same size, with the same
age and gender. Other important variables could then have
interacted in the etiology of cardiac injury and biased the find-
ings. From a theoretical point of view, however, because the
threshold tried to separate the studied population into two
subgroups (poor outcome versus good outcome), there was
no reason why this threshold was influenced by the incidence
of the outcome in the population. As we showed in our sub-
group analysis, the fact that the proportion of poor outcome
was expected to be greater in combined surgery did not influ-
ence the value of the threshold of cTnI, thus also justifying the
absence of matching according to risk stratification.
Fourth, our study provides some insights into the different
mechanisms involved in 'basal' and pathological postoperative
cTnI release in main types of adult cardiac surgery with CPB,
but do not test appropriate strategies to improve outcome in
identified high-risk patients. Futures studies should address
this important issue.
Fifth, our study was performed in low-risk patients. Further
studies are therefore required to determine whether our
results are applicable for more high-risk patients.
Finally, the study was conducted in a single centre. The thresh-
old values we reported must probably therefore be interpreted
with cautious. Moreover, the thresholds identified were those
associated with occurrence of a composite endpoint defined
as severe cardiac event and/or inhospital death. As death was
a rare event, the thresholds described here probably do not
apply to the prediction of death, which is probably associated
with higher values of cTnI, as previously described [11,12],
and may not apply to the prediction on a long-term basis [12].
Further studies should also address these two important
issues.
Conclusion
The magnitude of postoperative serum cTnI release in adult
cardiac surgery is related to the type of surgery, and combined
surgery  per se induces greater cTnI levels, even in the
absence of postoperative severe cardiac events or death.
Although our study shows that postoperative cTnI permits
early and accurate identification of patients at increased risk of
severe cardiac complications, it also demonstrates that differ-
ent thresholds of cTnI should be considered according to the
type of cardiac surgery.
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Key messages
￿  The magnitude of postoperative cTnI release following 
conventional adult cardiac surgery with CPB is related 
to the type of surgical procedure, even in the absence 
of an adverse postoperative outcome. The more the 
procedure is complex and prolonged, the more the cTnI 
release is increased, irrespective of the mechanism.
￿  Different thresholds of postoperative cTnI release 
should be considered according to the procedure type 
in clinical practice to predict early a poor outcome fol-
lowing conventional adult cardiac surgery with CPB.
￿  Despite the determination of a particular threshold of 
postoperative cTnI release in each type of cardiac sur-
gery, the accuracy of cTnI to predict a poor outcome 
following conventional adult cardiac surgery with CPB 
may be different among procedure types, being less 
accurate in combined surgery and in valve surgery than 
in coronary surgery.